Medicare Enrolled
Dr. Yvonne Hines, M.D.
Dermatopathology Physician · Attleboro, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hines from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hines?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hines
Dr. Yvonne Hines is a dermatopathology physician in Attleboro, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hines performed 2,641 Medicare services across 1,414 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hines received a total of $1,077 from 15 pharmaceutical and/or device companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hines is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 44% volume in MA
$1,077 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,641
Medicare services
Top 44% in MA for dermatopathology physician
1,414
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~132 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
835 | $93 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $65 | $175 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
361 | $58 | $273 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
225 | $5 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
124 | $64 | $105 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
101 | $72 | $248 |
| Shaving of skin growth, more than 2.0 cm Removal of a skin growth by shaving the surface with a blade. This procedure is performed on the body, arms, or legs when the growth exceeds 2.0 centimeters. |
88 | $98 | $407 |
| Tissue fungi or parasites test A laboratory test to detect the presence of fungi or parasites in a tissue sample. |
88 | $4 | $58 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
75 | $41 | $167 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
54 | $42 | $315 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
44 | $94 | $120 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
42 | $92 | $188 |
| Shaving of skin growth on face or mouth, larger than 2.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The growth being removed is larger than 2.0 centimeters in size. |
37 | $133 | $354 |
| Destruction of skin growth, 15 or more growths | 32 | $102 | $448 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
26 | $35 | $161 |
| Shaving of skin growth, larger than 2.0 cm This procedure involves the removal of a skin growth by shaving it off. It is performed on areas such as the scalp, neck, hands, feet, or genitals when the growth exceeds 2.0 cm in size. |
25 | $106 | $360 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
23 | $128 | $524 |
| Fungal culture test A laboratory test that grows and identifies mold or yeast from a sample to detect a fungal infection. |
22 | $8 | $106 |
| Fungal culture, yeast A laboratory test that grows and identifies yeast or fungal organisms from a sample to determine if an infection is present. |
22 | $10 | $137 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
19 | $139 | $464 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
13 | $97 | $304 |
| Removal of inflamed or infected skin, up to 10% of body surface This procedure involves the surgical removal of skin affected by inflammation or infection. It is performed when the affected area covers up to 10 percent of the patient's total body surface area. |
12 | $42 | $294 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $104 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,077
Total received (2018-2024)
Avg $154/year across 7 years
Top 47% in MA for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
52
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,077 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$176
2023
$95
2022
$50
2021
$85
2020
$58
2019
$182
2018
$428
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$81
Arcutis Biotherapeutics, Inc.
$40
Dermavant Sciences, Inc.
$30
Verrica Pharmaceuticals Inc.
$25
Top 3 companies account for 85.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$309
Mayne Pharma Inc.
$133
GENZYME CORPORATION
$103
E.R. Squibb & Sons, L.L.C.
$81
Galderma Laboratories, L.P.
$79
Arcutis Biotherapeutics, Inc.
$78
Paratek Pharmaceuticals, Inc.
$58
Ortho Dermatologics, a division of Bausch Health US, LLC
$40
LEO Pharma Inc.
$38
Mylan Pharmaceuticals Inc.
$36
Dermavant Sciences, Inc.
$30
Verrica Pharmaceuticals Inc.
$25
Cynosure, LLC
$24
Celgene Corporation
$24
Amgen Inc.
$19
Top 3 companies account for 50.6% of all-time payments
Associated products mentioned in payments ›
Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · HYLATOPIC EMOLLIENT · NUZYRA · ORACEA · Otezla · Sotyktu · VTAMA · YCANTH · Zoryve · surgitron
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatopathology physicians within 10 mi
4
Per 100K population
0.7
County median income
$84,198
Nearest hospital
STURDY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hines is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hines experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hines performed 835 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hines receive payments from pharmaceutical companies?
Yes. Dr. Hines received a total of $1,077 from 15 companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hines's costs compare to other dermatopathology physicians in Attleboro?
Dr. Hines's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hines) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Attleboro
Browse dermatopathology physicians in Attleboro ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in MA
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in MA
Which MA dermatopathology physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Mayne Pharma Inc. Payments to Doctors
See all physicians who received payments from Mayne Pharma Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology